Spinal Cord Injuries Clinical Trial
Official title:
Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury
The Investigators will recruit 50 participants with acute SCI (within 72 hours of injury) Fasting blood collection and bowel function survey will be conducted 4 times: at baseline [the time of first stool sample, within 72 hours of injury] and 1, 6, and 12 months after SCI. Stool will be collected for gut microbiome analysis 4 times
Status | Recruiting |
Enrollment | 50 |
Est. completion date | February 28, 2027 |
Est. primary completion date | December 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. 18-65 years of age 2. diagnosis of traumatic SCI at the cervical or thoracic level (C5-T6) 3. classification of A, B (motor complete, incomplete). Exclusion Criteria: 1. Women who are pregnant prior to consent 2. neurological impairment other than SCI 3. self-reported history of Crohn's disease or diverticulitis 4. irritable bowel syndrome 5. gastric blockage/obstruction or swallowing disorder 6. prior GI surgery 7. intrathecal pump 8. concurrent usage of functional electrical stimulation for bowel management (e.g., constipation). |
Country | Name | City | State |
---|---|---|---|
United States | The University of Alabama at Birmingahm | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Neurological impairment - Injury level by ISNCSCI | Injury level determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Baseline | |
Primary | Neurological impairment - Injury level by AIS | Injury level determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Baseline | |
Primary | Neurological impairment - completeness of injury by ISNCSCI | Completeness of injury determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Baseline | |
Primary | Neurological impairment - completeness of injury by AIS | Completeness of injury determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Baseline | |
Primary | Neurological impairment - Injury level by ISNCSCI | Injury level determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Month 6 | |
Primary | Neurological impairment - Injury level by AIS | Injury level determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Month 6 | |
Primary | Neurological impairment - completeness of injury by ISNCSCI | Completeness of injury determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Month 6 | |
Primary | Neurological impairment - completeness of injury by AIS | Completeness of injury determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Month 6 | |
Primary | Neurological impairment - Injury level by ISNCSCI | Injury level determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Month 12 | |
Primary | Neurological impairment - Injury level by AIS | Injury level determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Month 12 | |
Primary | Neurological impairment - completeness of injury by ISNCSCI | Completeness of injury determined by International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam | Month 12 | |
Primary | Neurological impairment - completeness of injury by AIS | Completeness of injury determined by American Spinal Injury Association Impairment Scale (AIS). classification. | Month 12 | |
Primary | Microbiome composition - Bacterial 16S rRNA sequincing | Bacterial 16S rRNA sequencing will be performed | Baseline | |
Primary | Microbiome composition - Bacterial 16S rRNA sequincing | Bacterial 16S rRNA sequencing will be performed | Month 1 | |
Primary | Microbiome composition - Bacterial 16S rRNA sequincing | Bacterial 16S rRNA sequencing will be performed | Month 6 | |
Primary | Microbiome composition - Bacterial 16S rRNA sequincing | Bacterial 16S rRNA sequencing will be performed | Month 12 | |
Primary | Microbiome composition - Metagenomics | A subset of 16S rRNA gene surveys that show differences in taxa and alpha and beta diversity are selected for follow-up via shotgun metagenomics. | Baseline | |
Primary | Microbiome composition - Metagenomics | A subset of 16S rRNA gene surveys that show differences in taxa and alpha and beta diversity are selected for follow-up via shotgun metagenomics. | Month 1 | |
Primary | Microbiome composition - Metagenomics | A subset of 16S rRNA gene surveys that show differences in taxa and alpha and beta diversity are selected for follow-up via shotgun metagenomics. | Month 6 | |
Primary | Microbiome composition - Metagenomics | A subset of 16S rRNA gene surveys that show differences in taxa and alpha and beta diversity are selected for follow-up via shotgun metagenomics. | Month 12 | |
Primary | Gut derived metabolites | Blood will be collected and serum extract metabolites will be isolated | Baseline | |
Primary | Gut derived metabolites | Blood will be collected and serum extract metabolites will be isolated | Month 1 | |
Primary | Gut derived metabolites | Blood will be collected and serum extract metabolites will be isolated | Month 6 | |
Primary | Gut derived metabolites | Blood will be collected and serum extract metabolites will be isolated | Month 12 | |
Primary | Analysis of metabolic markers to determine metabolic function | Blood will be collected and serum assays for metabolic markers performed | Baseline | |
Primary | Analysis of metabolic markers to determine metabolic function | Blood will be collected and serum assays for metabolic markers performed | Month 1 | |
Primary | Analysis of metabolic markers to determine metabolic function | Blood will be collected and serum assays for metabolic markers performed | Month 6 | |
Primary | Analysis of metabolic markers to determine metabolic function | Blood will be collected and serum assays for metabolic markers performed | Month 12 | |
Primary | Analysis of inflammatory markers to determine Inflammatory state | Blood will be collected and serum assays for inflammatory markers performed | Baseline | |
Primary | Analysis of inflammatory markers to determine Inflammatory state | Blood will be collected and serum assays for inflammatory markers performed | Month 1 | |
Primary | Analysis of inflammatory markers to determine Inflammatory state | Blood will be collected and serum assays for inflammatory markers performed | Month 6 | |
Primary | Analysis of inflammatory markers to determine Inflammatory state | Blood will be collected and serum assays for inflammatory markers performed | Month 12 | |
Primary | Bowel function - International Bowel Function Basic and Extended Data Set Assessment | International Bowel Function Basic and Extended Data Set assessment will be utilized to assess bowel-related symptoms. | Baseline | |
Primary | Bowel function - Bristol Stool Scale | Bristol Stool Scale assessment will be utilized to assess bowel-related symptoms. | Baseline | |
Primary | Bowel function - International Bowel Function Basic and Extended Data Set Assessment | International Bowel Function Basic and Extended Data Set assessment will be utilized to assess bowel-related symptoms. | Month 1 | |
Primary | Bowel function - Bristol Stool Scale | Bristol Stool Scale assessment will be utilized to assess bowel-related symptoms. | Month 1 | |
Primary | Bowel function - International Bowel Function Basic and Extended Data Set Assessment | International Bowel Function Basic and Extended Data Set assessment will be utilized to assess bowel-related symptoms. | Month 6 | |
Primary | Bowel function - Bristol Stool Scale | Bristol Stool Scale assessment will be utilized to assess bowel-related symptoms. | Month 6 | |
Primary | Bowel function - International Bowel Function Basic and Extended Data Set Assessment | International Bowel Function Basic and Extended Data Set assessment will be utilized to assess bowel-related symptoms. | Month 12 | |
Primary | Bowel function - Bristol Stool Scale | Bristol Stool Scale assessment will be utilized to assess bowel-related symptoms. | Month 12 | |
Secondary | Diet | Participant records 24-hour dietary recalls | Baseline | |
Secondary | Diet | Participant records 24-hour dietary recalls | Month 1 | |
Secondary | Diet | Participant records 24-hour dietary recalls | Month 6 | |
Secondary | Diet | Participant records 24-hour dietary recalls | Month 12 | |
Secondary | Physical activity - PARA-SCI | Complete PARA-SCI questionnaire to determine physical activity level | Baseline | |
Secondary | Physical activity - CDEs | Complete rehabilitation therapies survey (CDEs) to determine physical activity level | Baseline | |
Secondary | Physical activity - PARA-SCI | Complete PARA-SCI questionnaire to determine physical activity level | Month 1 | |
Secondary | Physical activity - CDEs | Complete rehabilitation therapies survey (CDEs) to determine physical activity level | Month 1 | |
Secondary | Physical activity - PARA-SCI | Complete PARA-SCI questionnaire to determine physical activity level | Month 6 | |
Secondary | Physical activity - CDEs | Complete rehabilitation therapies survey (CDEs) to determine physical activity level | Month 6 | |
Secondary | Physical activity - PARA-SCI | Complete PARA-SCI questionnaire to determine physical activity level | Month 12 | |
Secondary | Physical activity - CDEs | Complete rehabilitation therapies survey (CDEs) to determine physical activity level | Month 12 | |
Secondary | Medication List - Medical Record Review | Medical record review of prescribed medications being taken | Baseline | |
Secondary | Medication List - Self-report | Self-report of prescribed medications being taken | Baseline | |
Secondary | Medication List - Medical Record Review | Medical record review of prescribed medications being taken | Month 1 | |
Secondary | Medication List - Self-report | Self-report of prescribed medications being taken | Month 1 | |
Secondary | Medication List - Medical Record Review | Medical record review of prescribed medications being taken | Month 6 | |
Secondary | Medication List - Self-report | Self-report of prescribed medications being taken | Month 6 | |
Secondary | Medication List - Medical Record Review | Medical record review of prescribed medications being taken | Month 12 | |
Secondary | Medication List - Self-report | Self-report of prescribed medications being taken | Month 12 | |
Secondary | Supplement usage - Medical Record Review | Medical record review of supplements being taken | Baseline | |
Secondary | Supplement usage - self-report | Self-report of supplements being taken | Baseline | |
Secondary | Supplement usage - Medical Record Review | Medical record review of supplements being taken | Month 1 | |
Secondary | Supplement usage - self-report | Self-report of supplements being taken | Month 1 | |
Secondary | Supplement usage - Medical Record Review | Medical record review of supplements being taken | Month 6 | |
Secondary | Supplement usage - self-report | Self-report of supplements being taken | Month 6 | |
Secondary | Supplement usage - Medical Record Review | Medical record review of supplements being taken | Month 12 | |
Secondary | Supplement usage - self-report | Self-report of supplements being taken | Month 12 | |
Secondary | Depression | Complete PHQ9 questionnaires to determine depression level | Baseline | |
Secondary | Depression | Complete PHQ9 questionnaires to determine depression level | Month 1 | |
Secondary | Depression | Complete PHQ9 questionnaires to determine depression level | Month 6 | |
Secondary | Depression | Complete PHQ9 questionnaires to determine depression level | Month 12 | |
Secondary | Anxiety | Complete GAD7 questionnaire to determine anxiety level | Baseline | |
Secondary | Anxiety | Complete GAD7 questionnaire to determine anxiety level | Month 1 | |
Secondary | Anxiety | Complete GAD7 questionnaire to determine anxiety level | Month 6 | |
Secondary | Anxiety | Complete GAD7 questionnaire to determine anxiety level | Month 12 | |
Secondary | Comorbidities | Evaluate Medical history (CDEs) for any other comorbidities beyond GI dysfunction | Baseline | |
Secondary | Comorbidities | Evaluate Medical history (CDEs) for any other comorbidities beyond GI dysfunction | Month 1 | |
Secondary | Comorbidities | Evaluate Medical history (CDEs) for any other comorbidities beyond GI dysfunction | Month 6 | |
Secondary | Comorbidities | Evaluate Medical history (CDEs) for any other comorbidities beyond GI dysfunction | Month 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06321172 -
Muscle and Bone Changes After 6 Months of FES Cycling
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05484557 -
Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury
|
N/A | |
Suspended |
NCT05542238 -
The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury
|
N/A | |
Recruiting |
NCT05503316 -
The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System
|
N/A | |
Not yet recruiting |
NCT05506657 -
Early Intervention to Promote Return to Work for People With Spinal Cord Injury
|
N/A | |
Recruiting |
NCT03680872 -
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System
|
N/A | |
Recruiting |
NCT04105114 -
Transformation of Paralysis to Stepping
|
Early Phase 1 | |
Completed |
NCT04221373 -
Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation
|
N/A | |
Completed |
NCT00116337 -
Spinal Cord Stimulation to Restore Cough
|
N/A | |
Completed |
NCT03898700 -
Coaching for Caregivers of Children With Spinal Cord Injury
|
N/A | |
Recruiting |
NCT04883463 -
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
|
N/A | |
Active, not recruiting |
NCT04881565 -
Losing Balance to Prevent Falls After Spinal Cord Injury (RBT+FES)
|
N/A | |
Completed |
NCT04864262 -
Photovoice for Spinal Cord Injury to Prevent Falls
|
N/A | |
Recruiting |
NCT04007380 -
Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI
|
N/A | |
Active, not recruiting |
NCT04544761 -
Resilience in Persons Following Spinal Cord Injury
|
||
Terminated |
NCT03170557 -
Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation
|
N/A | |
Completed |
NCT03220451 -
Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients
|
N/A | |
Recruiting |
NCT04811235 -
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
|
N/A | |
Recruiting |
NCT04736849 -
Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury
|
N/A |